Settings

Sidenav Mini

Light/Dark

Money Monday January 9th 2023 Morning Stock Newsletter

 

🌟 Goooood Morning Traders and Happy Money Monday 🌟

WE ARE BACK!!! WWWOOOOOOOO

Today marks the start of a brand new day and a brand new week full of brand new opportunities in the market 💪 I am excited to work with each and everyone of you and I cannot wait to see what the market has in store for us!

Today is going to be an amazing day team and I am excited to crush it with you!!!!!

Live Stream is now up and Live Trade Commentary will begin at 9:00AM. 👏 👏 👏

 


STOCKS WITH NEWS

Stock futures rise to start the week as traders try to build on Friday’s rally https://www.cnbc.com/2023/01/08/stock-market-futures-open-to-close-news.html

Inverse ETF’s to be watching today if we see more downside and volatility in the markets today $SQQQ $SPXU $UVXY $SDS

Fridays top gainers $MLEC $SPRB $MMV $GSUN $HOLO $OCBR

$AMYT – Chiesi Farmaceutici S.p.A. To Acquire Amryt Pharma for $14.50/ADS Plus Contingent Value Rights Of Up To An Additional $2.50/ADS

$ALBO – Ipsen To Acquire Albireo For $42.00/Share Plus A Contingent Value Right Of $10.00/Share

$CINC – AstraZeneca acquire CinCor for $26/Share in Cash

$LULU – Lululemon falls 10% after setting holiday guidance below expectations

$PAYA – Nuvei Agrees to Buy Paya Holdings in $1.3 Billion Cash Deal; Paya Shares Rise Pre-Bell

$DCT – *Duck Creek to Be Acquired for $19/Share; Closed Friday at $12.99 >DCT

$CNTX – Context Therapeutics And Lonza Enter Manufacturing Agreement For Bispecific Antibody Targeting Claudin 6-Positive Cancers; Lonza To Provide Manufacturability Assessment, Gene And Cell Line Construction And Process Development

$VYGR – UPDATE: Voyager To Receive Up-front Consideration Of $175 Million Including A $39 Million Equity Investment, Up To $1.5 Billion In Potential Development Milestones, Additional Potential Commercial Milestones, Tiered Royalties On Net Sales, Program Funding, And An Option To Elect 50/50 Cost- And Profit-sharing In The U.s. For The Gba1 Program Following Phase 1 Readout

$KRON – Kronos Bio Announces Discovery Collaboration With Genentech To Advance Novel Therapies Against Transcriptional Targets In Oncology; Kronos To Receive $20M Upfront Payment And Up To $554M In Milestone Payments

$SONN – Sonnet BioTherapeutics Announces a Collaboration with Roche for the Clinical Evaluation of SON-1010 with atezolizumab in Ovarian Cancer

$SYTA – Siyata’s Next Generation Push-to-Talk Over Cellular SD7 Device to be Launched Across T-Mobile IoT Data Network

Daily game plans


PRE MARKET GAPPERS


Reddit Top Mentions


Market Overview


Largest Short Interest


Economic Calendar


PRIOR DAY TOP GAINERS


Earnings this Week